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Abstract
Background: The 10-Meter Walk Tests (10MWT) and the 6-Minute Walk Test (6MinWT) are applied to assess gait
capacity in paediatric patients. To better objectify changes in qualitative aspects of gait, temporo-spatial parameters
like stride length or step symmetry could be simultaneously assessed with a GAITRite system. Reliability has not yet
been evaluated in a heterogeneous sample of children with various neurological gait disorders such as is representative
for paediatric neuro-rehabilitation. The aim of this study was to assess test-retest reliability of the 10MWT, the 6MinWT
and simultaneously recorded gait parameters captured with the GAITRite system in children with neurological gait
disorders.
Methods: This is a cross-sectional study with two measurement time-points. Thirty participants (9 females; mean
(standard deviation) age 13.0 (3.6) years, 10 with cerebral palsy, 6 after stroke, among other diagnoses) performed the
10MWT at preferred (10MWTpref) and maximum speed (10MWTmax) and the 6MinWT on two occasions
(mean time interval: 7.0 (1.9) days). Relative reliability was quantified with an intra-class correlation coefficient
(ICC); the measurement error reflecting absolute reliability was quantified with the standard error of measurement and
the smallest real difference.
Results: ICCs of timed walking tests (time measured with a stopwatch, step count for the 10MWT and walking
distance for the 6MinWT) ranged from 0.89–0.97. ICCs of temporo-spatial gait parameters ranged from 0.81–0.95
(10MWTpref), from 0.61–0.90 (10MWTmax) and from 0.88–0.97 (6MinWT). In general, absolute reliability was greatest
in the 6MinWT.
Conclusion: Timed walking tests and temporo-spatial gait parameters obtained from the GAITRite system appear
reliable in children with neurological gait disorders. However, especially in children with poorer walking ability, the
reliability of temporo-spatial parameters might have been positively influenced, as unclear steps had to be removed
using the GAITRite software. As absolute reliability is rather low, the responsiveness of these measures needs to be
further evaluated.
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Background
Worldwide the prevalence of Cerebral Palsy (CP) varies
between 1.5 to 2.5 per 1000 births [1] and has increased
over the years [2]. While CP is the most common phys-
ical disability among children [3], traumatic brain injury
is also a leading cause of long-term disability among
children and young adults [4]. Also, children with stroke,
myelomeningocele, spinal cord injury, genetic disorders
or various developmental disorders are frequently under-
going paediatric neurorehabilitation; therefore, the popu-
lation in this field is very heterogeneous.
Many children with neurological disorders such as CP,
traumatic brain injury, or stroke and their parents priori-
tise walking above any other activities to be improved
during rehabilitation [5]. Therefore, to evaluate the ef-
fectiveness of the rehabilitation program, a careful evalu-
ation of walking ability is required. The international
classification of functioning, disability and health (ICF)
declares walking as an item on the activity and participa-
tion domain (WHO, 2001). Therefore, at least part of its
assessment should also occur in this domain.
The 10-Meter Walk Test (10MWT) and the 6-Minute
Walk Test (6MinWT) have often been used to assess
gait capacity in paediatric patients [6–8]. Commonly, the
time required to walk 10 m is recorded while the cov-
ered distance is measured for the 6MinWT.
Interestingly, while psychometric studies evaluating the
reliability of the 10MWT performed at a comfortable
speed in children with neurological disorders do not seem
to exist, test-retest reliability of the 10MWT performed at
fast speed proved to be acceptable [6]. Also, the 6MinWT
proved reliable when tested in healthy children [9], in chil-
dren with myelomeningocele [7] and CP [6, 8]. The test-
retest reliability of the 6MinWT was evaluated in a group
of 31 children with CP with a retest interval of 1 to
4 weeks [6] and in a sample of 41 children with CP, who
performed the test twice on the same day [8]. Bartels et al.
examined psychometric properties of the 6MinWT ad-
ministered in children with chronic paediatric conditions
[10]. In their recently published review, they stated that
there is little evidence available for responsiveness and
measurement error (i.e. absolute reliability).
Combining these tests simultaneously with the GAI-
TRite, which has to our knowledge not been done before,
provides additional information on temporo-spatial gait
parameters. These parameters allow an objective evalu-
ation of parameters reflecting the quality of gait since, for
example, step length or step time symmetry can be com-
puted. Wondra et al. [11] stated that these parameters are
often used for the assessment of treatment effects and to
expose irregularities in the gait pattern of children with
motor disabilities. Several studies showed that most
temporo-spatial gait parameters, including e.g. symmetry
of steps, were validly and reliably assessed by the
GAITRite system in healthy adults [12–14]. In children
with developmental coordination disorder, reliability dif-
fered considerably between gait parameters [15]. Reliabil-
ity was found to be satisfying in children with motor
disabilities (mostly CP) who walked barefoot or while
wearing shoes and orthoses [11] and in 18 children with a
mild CP (Gross Motor Function Classification System
(GMFCS) level I and II) [16].
Wondra et al. let their participants practice the walk test
and measured 6 to 10 trials [11]. This procedure might
lead to better reliability since the walks are practiced be-
fore the test. Same-day reliability testing is mentioned to
be crucial to determine therapeutical interventions with
immediate effects, such as when applying an orthosis [11].
In our case, to determine the outcome of a longer inter-
vention period, it makes sense to assess test-retest reliabil-
ity with an interval that is long enough to allow a certain
independence of the measurements, but short enough to
ensure that the patient’s performance remains stable.
To obtain reliable pre- and post-measurements it is
recommended to have the same person administering
both tests. Nevertheless, in the clinic it is often difficult
having the same tester performing both pre- and post-
assessments. Therefore, determining the reliability be-
tween different testers at different time points might
reflect better daily routines. In the studies by Wondra et
al. [11] and Sohrsdahl et al. [16] there is no information
about whether the same person did the tests or whether
there was more than one tester.
Even though reliability results obtained in very homo-
geneous patient groups might make sense for research
purposes, their generalizability to the clinics is very lim-
ited. The aim of this study was to evaluate the test-retest
reliability of the 10MWT performed at preferred speed
(10MWTpref), at maximum speed (10MWTmax) and
the 6MinWT, including temporo-spatial gait parameters
that were simultaneously collected in youths with neuro-
logical diagnoses. The first and second test session were
performed by different therapists to reflect the normal
daily scenario. According to the results presented by
Sorsdahl et al. [16] and Wondra et al. [11] and based on
our heterogeneous sample that we aimed to include, we
hypothesized that most of the parameters would reveal
good relative reliability (intra-class correlation coeffi-
cients (ICCs) > 0.8). According to our experience with
children, we hypothesized that most parameters would
show poor absolute reliability, i.e. considerable measure-
ment errors due to high within-subject variance.
Methods
Study design
In this cross-sectional study, two different assessors
(physiotherapists or movement scientists who had all re-
ceived the same training) performed two measurements
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within 14 days maximum (targeted was a between-test
interval of 7 days). Since we had to plan the time-points
within the regular ongoing rehabilitation program, we
choose this pragmatic time range. The rehabilitation
program consisted of physiotherapy, occupational ther-
apy, speech and language therapy, school, sports, and/or
robot-assisted training, according to the patients’ indi-
vidual goals.
Participants
For our convenience sample, we recruited inpatients of
the Rehabilitation Centre for Children and Adolescents
of the University Children’s Hospital Zurich in Affoltern
am Albis, Switzerland. We included youths between the
age of 5 and 20 years with gait disorders of neurological
origin. Participants had to be able to understand and fol-
low the instructions of the timed walking tests. Excluded
were children who were not able to walk without the
physical assistance of a person. Walking aids such as
walkers as well as orthoses of any kind were allowed. A
sample size of 25–30 participants was minimally re-
quired since such a sample size was suggested to calcu-
late an accurate estimate of the random error [17].
The Ethics Committee of the Canton of Zurich approved
this study. Children below 15 years provided verbal in-
formed consent. Legal representatives and adolescents aged
15 years and older signed a written informed consent.
Instrumentation
The GAITRite Electronic Walkway Platinum (CIR Sys-
tems Inc., Peekskill, N.Y., USA) has an active area of
61 cm × 488 cm containing 18’432 sensors (distance be-
tween sensors 1.27 cm). The system captures the geom-
etry and relative arrangement of each footfall as a
function of time at a sampling frequency of 120 Hz.
The walkway was placed in a long corridor in a calm
environment.
Procedures
For all timed walk tests, participants wore their regular
shoes and orthoses. Participants completed the three
timed walking tests in a calm corridor in the order
presented below.
10 Meter Walk Test at preferred speed
The time to walk across the 10 middle meters of a 14 m
long walkway was recorded (tape on the floor marked
the distances) to account for acceleration and deceler-
ation effects [16]. The GAITRite mat was placed at the
start of the 10 m walkway.
Participants were instructed the following: “Walk in
your normal, comfortable speed up to the last line.” This
test was repeated twice, with a short break in between.
We recorded the time in seconds and counted the
number of steps. The average value of the two measure-
ments was included in the analysis.
10 Meter Walk Test at maximum speed
The 10MWTmax was conducted similarly as the
10MWTpref. Participants were instructed as follows:
“Walk as fast as you can to the last line, but so that you are
still feeling safe and without running.” The test was also re-
peated twice, with a short break in between. Only data
from the fastest trial were included in the analysis, as this
test should indicate the participant’s maximal capacity.
6 Minute Walk Test
After a break of 5 to 10 min, participants performed the
6MinWT according to guidelines published by the
American Thoracic Society [18]. The participants walked
up and down 30 m. The GAITRite walkway was posi-
tioned 18 m after the start of the track (Fig. 1). Partici-
pants repeatedly walked over it.
At each end of the 30 m track, they circumvented a
pylon. Instructions and encouragement were standardized
throughout the test. “The aim of this test is to walk as far
as possible within 6 min. You walk up and down the hall-
way; every time you reach the end of the hallway you cir-
cumvent the pylon and walk back. If you are tired or
exhausted, you are allowed to walk slower, to stop or take a
break, but try to keep on walking as soon as possible. Re-
member, the aim is to walk as far as possible.” During the
test, verbal encouragement was given every minute, e.g.
after one minute: “You are doing well; you have five more
minutes to walk,” after two minutes: “Go on like this; you
have four more minutes to go,” etc. The child was
instructed to lean against the wall when it needed a break
and was informed to continue walking when being able to.
Participants were informed 15 s before the end of the tests
to stand still soon. The maximal distance covered during
6 min was determined and rounded to the next meter.
A trained physiotherapist performed manual muscle
testing of the hip extensor and flexor muscles, the ab-
and adductors, the internal and external rotators, the
knee extensors and –flexors, and the plantar and dorsi-
flexors of the ankle joint. Testing occurred after the
timed walking tests had been performed. The scores
were evaluated according to Durfee and Iaizzo [19].
Data processing
Simultaneously to the timed walk tests and the record-
ing of step count, and time needed to cover 10 meter
(10MWT) or distance walked during 6 minutes
(6MinWT), the GAITRite system captured the footfalls.
These were then processed into various temporo-spatial
gait parameters with the accompanying software. Incom-
plete footfalls, scrub marks and marks produced by
walking aids were deleted. Included were only walks
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with at least 4 footfalls. Data were then exported to
Microsoft Excel. For the 10MWTpref, the two trials
were averaged, while for the 10MWTmax, data from the
fastest trial (measured with a stopwatch) were selected.
For the 6MinWT, the average of all the walks crossing
the GAITRite was calculated.
We selected the following GAITRite parameters for ana-
lysis: velocity, cadence, double support as a percentage of
the gait cycle and step length, as the reliability of these pa-
rameters was also previously investigated [11, 16]. The pa-
rameters normalized velocity (ratio of velocity and leg
length), step-extremity-ratio (ratio of leg- and step-length)
and step time were chosen since we considered them im-
portant for describing a gait pattern. Double support, step
length, step-extremity-ratio and step time were determined
for the left and right leg and the more and the less affected
leg. The more affected leg was defined as the leg with the
smaller sum-score of muscle strength scores [20] (Table 1).
If the sum-score was the same on both legs, the left leg
was classified as more affected. Furthermore, we calculated
an absolute symmetry index (ASI) for the step time- and
step length-symmetry according to the following formula:
ASI =ABS[(2 × (XL − XR)/(XL + XR)) × 100] [21, 22].
Where XL refers to the according parameter of the left
leg and XR to the same parameter of the right leg and
ABS to the absolute value.
An absolute symmetry index value of 0 % refers to
perfect symmetry [22] while <10 % is considered normal
[23]. We considered symmetry important, as it reflected
a qualitative aspect of the gait pattern.
Data analysis
The statistical analyses were conducted with SPSS (IBM
SPSS Statistics V. 19.0). To test for systematic differences
between session 1 and session 2 for all parameters (e.g. an
improvement due to familiarization) we applied a Wil-
coxon signed rank test. To assess relative reliability a two-
way random model ICC (2,1) based on absolute agree-
ment was applied. The 95 % confidence interval was cal-
culated to specify the precision of the estimates. The ICCs
were evaluated according the Munro’s classification for
correlation coefficients: 0.00 to 0.25: little if any correl-
ation; 0.26 to 0.49: low correlation; 0.50 to 0.69: moderate
correlation; 0.70 to 0.89: high correlation; 0.90 to 1.00:
very high correlation [24]. Nunnally and Bernstein [25]
state that a reliability coefficient of 0.70 is sufficient in
early stages of research, but recommended are values of
0.80 or higher [26].
For absolute reliability the standard error of measure-
ment (SEM) and the smallest real difference (SRD) were
calculated according to the following formulas [27]:
SEM ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
σ2t þ σ2e
 q
SRD ¼ 1:96
ﬃﬃﬃ
2
p
 SEM
Here, σ2t refers to the variance of the trial and σ
2
e to
the variance of the residual error. The units of SEM and
SRD are those of the particular parameter. To be able to
compare the absolute reliability measures between vari-
ous parameters or various tests, the SEM% and SRD%
were calculated as SEM% ¼ SEM  Xð Þ  100 , and SR
D% ¼ SRD Xð Þ  100 respectively where is the grand
mean of the correspondent parameter of session 1 and 2 [28].
Data were presented as means and standard deviations
(SD), despite that most data were not normally distrib-
uted. Mean and SD values should enable future studies to
use these data for, for example, sample size calculations.
Fig. 1 Setup of the (a) 10-Meter Walk Test and (b) 6-Minute Walk Test. Shown is the position of the GAITRite walkway in relation to the start of
the timed walk tests. For the 6-Minute Walk Test, participants walked repetitively over the GAITRite (walking up and down the corridor)
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To determine differences in relative and absolute reliabil-
ity between the 10MWTpref, 10MWTmax and the
6MinWT, the ICC and the SEM% values of the temporo-
spatial gait parameters were compared among the three
timed walking tests with a Friedman’s test and consecutive
Wilcoxon tests. For the Wilcoxon tests, a Bonferroni cor-
rection was applied and α was set at 0.025, as each dataset
was included twice.
Table 1 Participant characteristics
Sex 9 girls, 21 boys
Mean (SD) age, years 13.0 (3.6)
Mean (SD) weight, kg 44.9 (16.9)
Mean (SD) height, cm 151.2 (18.3)
Values of MMT (Maximum: 45 points/leg) Points
Mean (SD) sum score
Left leg 33.9 (8.5)
Right leg 33.7 (8.4)
More affected leg 32.4 (8.2)
Less affected leg 35.2 (8.4)
Diagnoses Participants Time since injury/diagnosis/surgery
n Mean (min-max), days
Cerebral palsy 10
GMFCS level II: 3
GMFCS level III: 2
Missing GMFCS level: 5
Postsurgery: osteotomy of the femur (right side) 1 132
Postsurgery: selective dorsal rhizotomy 1 102
Postsurgery: shortening of ligamenta patellae (both sides) 1 96
Postsurgery: osteotomy of the femur (right side)/tendon lengthening and shortening 1 82/63
Stroke 6 177 (43–305); one congenital
Traumatic brain injury 6 105 (40–309)
Demyelination of CNS 2 54; one congenital
Astrocytome 2 90 (76–103)
Postinfectuous encephalopathy 1 299
Medulla blastoma 1 1351
Transverse myelopathy 1 74
Ataxia, unclear aetiology 1 Congenital
Walking ability Participants
n
Independent walker 23
Walking aids:
Walker 4
Crutches 2
4 point crutches 1
Orthoses:
Ankle-foot orthoses 8
Insoles 3
Foot lifter splint (one side) 1
MMT manual muscle test (values 0 to 5 points where 0 is no activation at all and 5 maximal force against resistance. Nine muscles of each leg were tested,
therefore the maximum sum-score is 45 points per leg), GMFCS Gross Motor Function Classification System, CNS central nervous system
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Results
Recruited were 35 participants. Due to technical difficul-
ties, data of two participants could not be used, and
three participants were incompliant. Demographical and
clinical characteristics of the remaining 30 participants
are shown in Table 1. Mean time interval (SD) between
test and retest was 7.0 (1.8) days (range: 4–12 days).
All participants had complete 10MWTpref and
10MWTmax datasets. Three 6MinWT datasets were ex-
cluded: one participant became incompliant during test-
ing while technical problems with the GAITRite resulted
in the loss of two datasets and a reduction of 61 cm in
active measurement area in 7 datasets (which reduced
the number of recorded footfalls by one or two).
Means, SDs, and results of the Wilcoxon signed rank
tests between session 1 and 2 of all the parameters (conven-
tional parameters: stopwatch time, step count, and walking
distance and the GAITRite parameters) are displayed in
Table 2. Measurement results are also displayed in Fig. 2.
Relative reliability varied considerably between the pa-
rameters (0.61 < ICC < 0.97) (see also Table 3). ICCs of
the 10MWTpref and the 6MinWT met or exceeded the
minimum acceptable value of 0.80. 10MWTmax ICC
values varied from moderate to very high while 4/23 pa-
rameters did not achieve the level of 0.70.
The median ICC value calculated from all 21 GAI-
TRite parameter ICC values (Table 3) was 0.93 for the
6MinWT, 0.87 for the 10MWTpref and 0.74 for the
10MWTmax. The ICC values differed between the three
tests (p <0.001) and were higher for the 6MinWT com-
pared to 10MWTpref and 10MWTmax (for both: p <
0.001) and also higher for the 10MWTpref compared to
the 10MWTmax (p = 0.002). Therefore, the relative reli-
ability of the GAITRite parameters of the three walking
tests can be ordered from better to worse as 6MinWT >
10MWTpref > 10MWTmax.
Absolute reliability values of the conventional parame-
ters, expressed as SEM%, of the time needed to cover 10
m were twice as high (10MWTpref: 28.3 %; 10MWTmax:
23.7 %) compared to the walking distance of the 6MinWT
(14.1 %, see Table 3). For the GAITRite parameters,
SEM% values varied between 4.36 % (extremity-step ratio
right leg recorded during the 6MinWT) and 80.71 % (step
length symmetry calculated for the 10MWTmax) of the
grand mean of the first and second measurement. The
median SEM% values calculated from all 21 GAITRite
parameter SEM% values (Table 3) were 11.04 for the
6MinWT, 18.88 for the 10MWTpref and 14.59 for the
10MWTmax. In line with the ICC results, SEM% values
differed significantly between the tests (Friedman’s
test: p < 0.001) and were smallest for the 6MinWT
compared to 10MWTpref (p = 0.001) and 10MWTmax
(p = 0.001). No significant difference could be found
between the 10MWTpref compared to the 10MWTmax
(p = 0.498). Therefore, absolute reliability of the GAITRite
parameters was better for the 6MinWT compared to the
two other tests.
Discussion
The aim of this study was to establish test-retest reliabil-
ity of the conventional and the GAITRite parameters of
the 10MWTpref, the 10MWTmax, and the 6MinWT.
Results showed high to very high relative reliability in
conventional gait parameters like the time needed to
cover 10 m or the distance covered during 6 min. GAI-
TRite parameters recorded during the 6MinWT showed
the highest relative and absolute reliability. Second best
was the 10MWTpref.
We could not completely confirm our first hypothesis
that all the three tests would show good relative reliabil-
ity. Although the lowest ICC values were still moderate,
this is considered not sufficient for tests used to reveal
improvement in gait. For the 10MWTmax, only 10 out
of 23 parameters showed high or very high relative reli-
ability (ICC ≥ 0.80), while all the parameters of the
10MWTpref and the 6MinWT exceeded this threshold.
Concerning our second hypothesis, some parameters
showed a low absolute reliability (i.e. considerable meas-
urement errors) between the two sessions. The rather
low relative and absolute reliability of the 10MWTmax
might be partially explained by its accomplishment.
Since we evaluated only the fastest trial, we did not aver-
age two or more walks as for the other tests. Averaging
several trials reduces variability, which could have in-
creased the reliability. This approach is supported by the
observation that the 6MinWT shows the greatest relative
and absolute reliability, as there was a mean of 12.67
(SD 4.86, Range 1–22) walks used for analysis in session
1, and a mean of 12.56 (SD 5.64, Range 1–27) walks in
session 2.
The results of the reliability of conventional gait pa-
rameters are partially consistent with the findings of
other studies. Compared to results obtained in children
with CP by Thompson et al. [6] the present study re-
vealed higher ICCs and smaller SEM and SRD for the
parameter time during the 10MWTmax. In the study of
Thompson et al., a period of up to 4 weeks lay between
the time-points of measurement [6], which could have
led to a more variable performance of the participants
between the sessions. Despite that the participants per-
formed the 10MWTmax 1.5 s faster at the second time
point (3.1 s faster in a subgroup with GMFCS level III),
this change was not significantly different [6]. For the
walking distance (6MinWT), however, relative and espe-
cially absolute reliability was reported to be considerably
better than the results found in our study [6, 8]. In the
study by Maher et al., the time between the two 6MinWT
measurements lasted only 30 min [8]. Retesting within
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Table 2 Means of all the parameters and results of the Wilcoxon signed rank test between session 1 and 2
Parameter 10MWTpref 10MWTmax 6MinWT
Session 1 Session 2 Wilcoxon Session 1 Session 2 Wilcoxon Session 1 Session 2 Wilcoxon
Mean (SD) Mean (SD) MD p-value Mean (SD) Mean (SD) MD p-value Mean (SD) Mean (SD) MD p-value
Conventional parameters
Time (stopwatch) (s) 12.62 (8.35) 12.93 (12.33) 0.26 0.48 7.61 (4.84) 7.95 (6.21) −0.03 0.76 NA NA NA NA
Step count (n steps) 20.22 (6.41) 20.00 (7.43) 0.00 0.53 16.47 (4.86) 16.80 (5.16) 0.00 0.17 NA NA NA NA
Walking distance (m) NA NA NA NA NA NA NA NA 414.93 (155.37) 408.78 (162.96) 0.00 0.69
GAITRite parameters
Velocity (m/s) 0.97 (0.33) 1.02 (0.34) −0.04 0.11 1.52 (0.49) 1.51 (0.52) 0.00 0.98 1.26 (0.42) 1.28 (0.47) 0.01 0.92
Normalized velocity (m/s) 1.26 (0.44) 1.34 (0.44) −0.05 0.09 2.00 (0.74) 1.97 (0.67) −0.01 0.93 1.66 (0.54) 1.66 (0.57) 0.01 1.00
Cadence (steps/min) 101.72 (20.17) 104.95 (20.65) −2.13 0.70 133.44 (30.79) 133.83 (29.56) −3.10 0.80 116.50 (24.04) 116.66 (25.80) 0.64 0.87
Extremity-step-ratio L 0.70 (0.17) 0.73 (0.18) −0.02 0.06 0.87 (0.19) 0.86 (0.19) 0.03 0.46 0.82 (0.18) 0.82 (0.18) 0.00 0.92
Extremity-step-ratio R 0.75 (0.15) 0.76 (0.15) −0.02 0.44 0.89 (0.18) 0.88 (0.19) 0.03 0.27 0.84 (0.15) 0.84 (0.16) −0.01 0.98
Extremity-step-ratio MA 0.70 (0.17) 0.73 (0.18) −0.02 0.05 0.87 (0.19) 0.87 (0.20) 0.01 0.83 0.82 (0.18) 0.82 (0.19) 0.00 0.79
Extremity-step-ratio LA 0.74 (0.15) 0.76 (0.15) −0.01 0.55 0.89 (0.18) 0.86 (0.18) 0.04 0.09 0.83 (0.16) 0.83 (0.16) −0.01 0.83
Double support L (% GC) 30.95 (10.15) 29.89 (10.63) 0.85 0.25 21.97 (7.38) 22.50 (9.19) −0.50 0.70 26.52 (9.83) 27.13 (11.93) −0.72 0.40
Double support R (% GC) 31.06 (9.98) 29.74 (10.73) 1.08 0.21 21.88 (7.52) 22.11 (9.08) 0.35 0.55 26.78 (10.46) 27.19 (12.03) −0.25 0.55
Double support MA (% GC) 30.95 (10.16) 29.95 (10.70) 0.75 0.28 21.90 (7.34) 22.46 (9.22) −0.20 0.67 26.58 (9.84) 26.99 (11.81) −0.54 0.65
Double support LA (% GC) 31.06 (9.97) 29.68 (10.66) 1.15 0.18 21.95 (7.57) 22.15 (9.05) 0.60 0.53 26.72 (10.45) 27.33 (12.15) −0.25 0.37
Step time L (s) 0.59 (0.12) 0.57 (0.11) 0.02 0.04 0.46 (0.09) 0.46 (0.12) 0.01 0.90 0.54 (0.15) 0.54 (0.17) 0.01 0.87
Step time R (s) 0.64 (0.24) 0.65 (0.31) 0.02 0.33 0.48 (0.14) 0.49 (0.17) 0.00 0.77 0.57 (0.23) 0.59 (0.33) −0.01 0.67
Step time MA (s) 0.61 (0.12) 0.59 (0.11) 0.01 0.08 0.47 (0.09) 0.47 (0.11) 0.00 0.71 0.55 (0.14) 0.55 (0.16) 0.00 0.98
Step time LA (s) 0.63 (0.24) 0.63 (0.32) 0.02 0.27 0.48 (0.14) 0.48 (0.18) 0.00 0.80 0.56 (0.24) 0.58 (0.33) −0.01 0.67
Step time symmetry (%) 12.21 (16.46) 12.48 (16.85) 0.41 0.89 8.91 (8.78) 9.34 (11.69) 0.92 0.81 10.08 (10.18) 9.62 (11.47) 0.29 0.20
Step length L (cm) 53.59 (14.51) 55.94 (15.13) −1.42 0.06 66.65 (16.20) 65.09 (17.39) 1.30 0.42 61.69 (16.03) 62.92 (16.14) −0.90 0.20
Step length R (cm) 57.47 (14.41) 58.91 (14.28) −1.17 0.39 68.66 (16.70) 67.78 (17.92) 2.57 0.45 62.14 (15.42) 64.38 (15.23) −1.06 0.06
Step length MA (cm) 53.94 (14.52) 56.46 (15.19) −1.81 0.04 67.06 (16.99) 66.13 (18.36) 0.09 0.61 61.91 (16.08) 63.17 (16.22) −0.57 0.15
Step length LA (cm) 57.12 (14.49) 58.39 (14.30) −0.92 0.54 68.25 (15.93) 66.74 (17.02) 3.18 0.22 61.92 (15.37) 64.12 (15.16) −1.24 0.07
Step length symmetry (%) 12.67 (17.52) 11.42 (19.56) 0.79 0.35 8.93 (8.65) 10.33 (10.56) −0.20 0.52 10.10 (14.86) 9.15 (12.67) 0.71 0.26
Symmetries are displayed in percentages where a value between 0 and 10 % refers to normal symmetry
p-value of Wilcoxon signed rank test
bold values refer to significance (p < 0.05)
10MWTpref 10 meter walk test at preferred speed, 10MWTmax 10 meter walk test at maximum speed, 6MinWT 6 min walk tests, % GC percentage of the gait cycle, SD standard deviation, MD median of differences, L
left leg, R right leg, LA less affected leg, MA more affected leg, NA not applicable
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Fig. 2 (See legend on next page.)
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such a short interval might increase reliability due to the
dependence of the measurements. Also in the population
of children with myelomeningocele, walking distance ap-
peared more reliable compared to our findings [7]. These
children were retested two weeks later and therewith the
protocol was more comparable to our study [7]. An im-
portant difference that might have led to better results in
the study by Maher et al. is the higher level of standardisa-
tion: the same tester administered the tests at the same
time of day [7]. On the contrary, in our study, we wanted
to resemble the clinical situation and abdicated on pur-
pose on a high level of standardisation. In the population
of children with cystic fibrosis comparable results of
agreements were observed, as the bias (i.e. the aver-
age difference between the first and second measure-
ment) was −15.9 m and the limits of agreement were
100.9 m and −132.9 m (Bland-Altman plot) [29].
The results of the GAITRite parameters of the present
study are comparable to the results obtained in the study
by Wondra et al. [11], where 80 % of the parameters met
the ICC threshold of ≥ 0.80 (single and multiple trials,
barefoot and with shoes and orthosis) in children with
motor disabilities. Considering heterogeneity between
the participants, the samples of their and our study are
quite comparable. As ICCs depend on the between-
subject variance (i.e. a larger between-subject variance
leads to greater ICCs), ICCs are usually high in hetero-
geneous patient groups. This fact has to be considered
when discussing these results. Nevertheless, while
Sorsdahl et al. [16] investigated test-retest reliability of
gait parameters in a rather homogenous group of chil-
dren with CP (GMFCS levels I and II), they also found
(very) high relative reliability, except for the parameter
step width, which was not evaluated in our study. The
study by Morrison et al. [15] investigating children with
developmental coordination disorder. Here, the authors
concluded that the wide range of ICC values they ob-
tained could be explained by the variable and inconsist-
ent gait pattern of these children, which could have
resulted in low ICC scores [14].
As previously stated, also our second hypothesis that
absolute reliability will show considerable measurement
errors could be confirmed. While SEM values for the
parameter cadence were comparable to the results ob-
tained by Wondra et al. [11], the SEM values for the par-
ameter velocity were larger in our study. The time
window between the testing might explain this. Wondra
et al. performed their tests on one day, which reduces
e.g. the influence of the participant’s day’s form, and,
therefore, might lead to more reliable performance [11].
One important aim of this study was to investigate the
reliability of the step time- and step length-symmetry, as
possible parameters to quantify the quality of gait. While
the average symmetry values were quite comparable be-
tween the three tests (table 2), the ICC values appeared
only excellent for the 10MWTpref and 6MinWT.
Sorsdahl et al. [15] also determined the relative reliability
of the asymmetry of the step length and found an ICC
of 0.82. Their and our test procedures were different: the
participants walked barefoot and without their orthosis
at self-selected, slow and fast speed, a total of eight
walks over a 5.88 m GAITRite walkway. Start and end
were 1.5 m before and after the walkway. In the current
study, ICC values were better for the 6MinWT and
10MWTpref, but poorer for the 10MWTmax. Symmetry
indices were also evaluated in adult patients with stroke
[30]. In that study, a step length asymmetry ratio was
calculated. Despite differences in calculation, they re-
ported similar ICC values for step length symmetry (ICC
0.81 for one walk, 0.92 for six walks) [30].
Nevertheless, absolute reliability values proved to be ut-
terly poor. SRD% of step length symmetry exceeded 100 %
in all three tests, for step time symmetry in the
10MWTmax. We conclude, therefore, that these sym-
metry parameters appeared promising when considering
the quantification of gait quality but, unfortunately, they
do not appear reliable enough for longitudinal evaluation.
Methodological considerations
The heterogeneity of children included in this study re-
flects the population of children with gait impairments
in paediatric neuro-rehabilitation, which is important to
determine the generalizability of our results. If these as-
sessments are used for research purposes the examin-
ation of reliability in specific populations is needed, [31]
since reliability is described as a varying feature and de-
pends on the tested population [24].
Interestingly, the participants walked on average sub-
stantially faster during the 6MinWT compared to the
10MWTpref. We hypothesise that this observation is
caused by the test instructions. While, for the
10MWTpref, the children were instructed to walk at a
self-selected comfortable speed, they had to cover as
much distance as possible during the 6MinWT. Appar-
ently, the children were able to walk at such a higher-
than-comfortable speed for 6 min.
(See figure on previous page.)
Fig. 2 Scatter-plots showing the results of the first and second assessment of the time needed to cover 10 m at (a) preferred or (c) maximum
speed, or (e) the distance covered during 6 min. Shown are also the repeated assessments of the absolute symmetry index calculated for the
step length for the (b) 10-min walking test performed at preferred speed (10MWTpref), (d) 10-min walking test performed at maximum speed
(10MWTmax) and (f) 6-min walking test (6MinWT)
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Table 3 Relative and absolute reliability measures of all the parameters and walk tests
Parameters 10MWTpref 10MWTmax 6MinWT
ICC (95 % CI) SEM SRD SEM% SRD% ICC (95 % CI) SEM SRD SEM% SRD% ICC (95 % CI) SEM SRD SEM% SRD%
Conventional parameters
Time (stopwatch) (s) 0.90 (0.80–0.95) 3.61 10.00 28.26 78.33 0.95 (0.89–0.98) 1.84 5.11 23.69 65.67 NA NA NA NA NA
Step count (n steps) 0.93 (0.85–0.96) 2.09 5.80 10.40 28.83 0.97 (0.93–0.98) 1.58 4.39 9.52 26.38 NA NA NA NA NA
Walking distance (m) NA NA NA NA NA NA NA NA NA NA 0.89 (0.77–0.95) 58.02 160.82 14.09 39.05
GAITRite parameters
Velocity (m/s) 0.82 (0.66–0.91) 0.26 0.72 26.09 72.25 0.86 (0.73–0.93) 0.20 0.55 13.22 36.36 0.90 (0.80–0.96) 0.14 0.40 11.38 31.55
Normalized velocity (m/s) 0.83 (0.67–0.92) 0.38 1.04 29.28 80.13 0.86 (0.73–0.93) 0.29 0.82 14.59 41.26 0.90 (0.79–0.95) 0.18 0.50 10.83 30.02
Cadence (steps/min) 0.88 (0.76–0.94) 14.20 39.37 13.74 38.10 0.70 (0.45–0.84) 16.92 46.91 12.66 35.10 0.88 (0.75–0.94) 8.93 24.76 7.66 21.24
Extremity-step-ratio L 0.87 (0.74–0.94) 0.13 0.36 18.28 50.62 0.89 (0.78–0.94) 0.08 0.21 9.29 24.39 0.96 (0.92–0.98) 0.04 0.10 4.36 12.09
Extremity-step-ratio R 0.82 (0.66–0.91) 0.09 0.26 11.93 34.46 0.90 (0.81–0.95) 0.09 0.24 10.19 27.16 0.93 (0.86–0.97) 0.04 0.12 5.15 14.29
Extremity-step-ratio MA 0.88 (0.75–0.94) 0.14 0.38 19.53 53.01 0.90 (0.81–0.95) 0.06 0.17 6.91 19.57 0.96 (0.92–0.98) 0.04 0.10 4.51 12.49
Extremity-step-ratio LA 0.81 (0.65–0.91) 0.09 0.25 12.02 33.38 0.89 (0.78–0.95) 0.12 0.32 13.70 36.53 0.94 (0.86–0.97) 0.04 0.11 4.94 13.68
Double support L (% of the gait cycle) 0.84 (0.68–0.92) 5.89 16.34 19.36 53.72 0.75 (0.53–0.87) 4.73 13.11 21.27 58.97 0.93 (0.85–0.97) 3.70 10.26 13.80 38.24
Double support R (% of the gait cycle) 0.82 (0.67–0.91) 6.72 18.61 22.11 61.22 0.74 (0.51–0.86) 4.43 12.29 20.14 55.87 0.95 (0.89–0.87) 2.98 8.26 11.04 30.61
Double support MA (% of the gait cycle) 0.84 (0.68–0.92) 5.75 15.93 18.88 52.32 0.75 (0.53–0.87) 4.76 13.21 21.46 59.55 0.94 (0.87–0.97) 3.15 8.74 11.77 32.63
Double support LA (% of the gait cycle) 0.82 (0.66–0.91) 6.88 19.08 22.65 62.83 0.73 (0.51–0.86) 4.42 12.26 20.05 55.61 0.94 (0.88–0.97) 3.55 9.85 13.15 36.45
Step time L (s) 0.82 (0.64–0.91) 0.11 0.31 18.92 53.32 0.73 (0.50–0.86) 0.06 0.16 12.96 34.56 0.93 (0.85–0.97) 0.04 0.12 8.09 22.41
Step time R (s) 0.94 (0.87–0.97) 0.07 0.20 10.84 30.96 0.87 (0.75–0.94) 0.07 0.18 14.46 37.17 0.93 (0.85–0.97) 0.11 0.30 18.78 52.05
Step time MA (s) 0.81 (0.63–0.90) 0.11 0.30 18.37 50.09 0.75 (0.53–0.87) 0.06 0.16 12.72 33.92 0.92 (0.83–0.96) 0.04 0.12 7.96 22.07
Step time LA (s) 0.94 (0.87–0.97) 0.07 0.20 11.14 31.83 0.86 (0.73–0.93) 0.06 0.17 12.62 35.75 0.93 (0.85–0.97) 0.11 0.30 18.93 52.48
Step time symmetry (%) 0.94 (0.87–0.97) 4.40 12.21 35.66 98.84 0.77 (0.75–0.88) 5.27 14.60 57.71 159.97 0.96 (0.92–0.98) 2.67 7.41 27.14 75.22
Step length L (cm) 0.90 (0.79–0.95) 10.17 28.18 18.57 51.46 0.68 (0.42–0.83) 11.35 31.45 17.23 47.75 0.97 (0.93–0.98) 5.35 14.84 8.59 23.82
Step length R (cm) 0.88 (0.76–0.94) 7.51 20.83 12.91 35.80 0.64 (0.37–0.81) 11.00 30.49 16.12 44.69 0.93 (0.84–0.97) 9.12 25.28 14.42 39.96
Step length MA (cm) 0.90 (0.79–0.95) 10.73 29.73 19.44 53.86 0.71 (0.47–0.85) 10.29 28.52 15.45 42.83 0.97 (0.93–0.98) 5.45 15.10 8.71 24.15
Step length LA (cm) 0.87 (0.79–0.95) 7.08 19.63 12.26 33.99 0.61 (0.32–0.79) 11.96 33.16 17.72 49.13 0.93 (0.83–0.97) 9.02 25.00 14.31 39.67
Step length symmetry (%) 0.95 (0.89–0.97) 6.39 17.72 53.08 147.13 0.67 (0.41–0.83) 7.78 21.55 80.71 223.72 0.94 (0.88–0.97) 4.79 13.28 49.77 137.95
10MWTpref 10 meter walk test at preferred speed, 10MWTmax 10 meter walk test at maximum speed, 6MinWT 6 minute walk tests, ICC intraclass correlation coefficient. 95 % CI 95 % confidence interval, SEM standard
error of measurement, SRD smallest real difference, SEM% percentage of the standard error of measurement of the grand mean, SRD% percentage of the smallest real difference of the grand mean, NA not applicable
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We assume that the quality of gait of the most severely
affected youths was overestimated by the GAITRite, as,
for those with poor walking ability, data of the walk re-
quired considerable editing with the GAITRite software.
By deleting unclear steps, the quality of the walk im-
proved. Editing might also have introduced a higher sus-
ceptibility to a bias of the investigator due to unclear
decisions on when and how to edit data. Despite that dif-
ferent people edited the walks, they all performed this ac-
cording to internally formulated guidelines. However, as
each walking pattern has its specific characteristics that
cannot be described in such guidelines, editing remains to
a certain extent subjective. This might have impacted our
results (but also those of other GAITRite studies).
Younger children and those with reduced cognitive abil-
ities, although able to follow test instructions, showed
quite large differences between the first and second ses-
sion. This bias might be largely due to a lack of motiv-
ation. Motivational aspects have to be kept in mind since
they might strongly affect the reliability of any assessment.
ICCs are largely influenced by between-subject variabil-
ity, i.e. a high ICC does not necessarily also reflect a high
absolute reliability. See for example Fig. 2b and f where
heterogeneous distributions of absolute step length sym-
metry indices of 10MWTpref and 6MinWT result in ex-
cellent ICC values despite poor absolute reliability values.
In clinical and research practice, it is very difficult to make
judgements on improvements in individual patients when
you have only information about relative reliability. There-
fore, we deemed it necessary to investigate also the abso-
lute reliability, i.e. measurement errors. An SRD value
informs you what change a patient should achieve before
this could be considered a true change, i.e. above chance.
Compared to other studies (for example Wondra et al.
[11]), we chose a relatively conservative way of calculating
the SEM and SRD values, because we included systematic
bias, which is not always done.
Limitations of the study
There are limitations that have to be mentioned. The sam-
ple size of our study was rather small, and the sample was
very heterogeneous due to the different diagnoses, severity
levels and walking abilities. A heterogeneous sample in-
volves large between-subject variance, which results in
high relative reliability. Nevertheless, as we wanted to pic-
ture reliability of a clinical setting, we decided to keep the
sample as heterogeneous as it was. One advantage of a
heterogeneous sample is that results can be generalised to
a broader population.
The participants were wearing the same orthosis and
used the same walking aids for both measurements. Fur-
thermore, we also tried to schedule the measurement
time-points at the same time of the day. Since our study
was conducted parallel to the rehabilitation programme,
this was not always possible. Other factors such as medi-
cation, daily activity, and others that we did not control
for, might have influenced reliability to a certain extent.
Clinical implications
A few practical issues have to be mentioned when using
the GAITRite walkway system. Firstly, small children might
not be heavy enough for the walkway [12]. In our experi-
ence, GAITRite measurements are difficult with children
with a bodyweight of less than 15 kg since there is not
enough pressure on the sensors and the GAITRite does
not recognize that there is still a walk in progress. The re-
cording of the walk will stop before it is finished. Secondly,
editing difficult walks should be standardised by formulat-
ing standardised guidelines, so all walks are edited the
same way. Thirdly, automatic and manual editing errors
occur. Some are obvious (e.g. calculations are done with 7
steps instead of 8 that are shown in the walk); however, the
number of non-recognizable errors is difficult to estimate.
To get a reliable result, several repetitions are recom-
mended, and this can be applied to any test. Nevertheless,
the motivational factor and the compliance of the person
doing the test must be considered. Compliance decreases
with the increasing number of trials, especially in the paedi-
atric field. This might influence reliability to a large extent.
Finally, for clinical purposes, we do not recommend
the repeated use of the GAITRite walkway during the
6MinWT because due to a large number of walks, the
time required for editing and analysing is considerable.
Conclusions
The timed walking tests and the simultaneously mea-
sured temporo-spatial gait parameters showed moderate
to very high relative reliability in all the three timed
walking tests. In general, absolute reliability was rather
low. Parameters recorded during the 10MWTmax
showed lowest relative reliability. Symmetry indices are
difficult to use for evaluation purposes, because of poor
absolute reliability. The use of the GAITRite system in a
paediatric neurorehabilitation setting has its advantages
but also disadvantages, as that gait quality of smaller
children and those with more severely affected walking
ability is likely to become overestimated because unclear
steps have to be removed from the analysis.
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